These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20591025)

  • 1. The CARI guidelines. Donors at risk: impaired glucose tolerance.
    Boudville N; Isbel N;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S133-6. PubMed ID: 20591025
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Donors at risk: obesity.
    Isbel N;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S121-32. PubMed ID: 20591024
    [No Abstract]   [Full Text] [Related]  

  • 3. The CARI guidelines. Donors at risk: haematuria.
    Ierino F; Kanellis J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S111-3. PubMed ID: 20591021
    [No Abstract]   [Full Text] [Related]  

  • 4. The CARI guidelines. Donors at risk: hypertension.
    Ierino F; Boudville N; Kanellis J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S114-20. PubMed ID: 20591022
    [No Abstract]   [Full Text] [Related]  

  • 5. The CARI guidelines. Donors at risk: proteinuria.
    Boudville N; Kanellis J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S106-10. PubMed ID: 20591020
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant-associated hyperglycemia: shedding light on the mechanisms.
    Reese PP; Bloom RD
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):560-2. PubMed ID: 20338965
    [No Abstract]   [Full Text] [Related]  

  • 8. Should living kidney donor candidates with impaired fasting glucose donate?
    Vigneault CB; Asch WS; Dahl NK; Bia MJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2054-9. PubMed ID: 21784837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic investigation on the incidence of diabetes mellitus from impaired glucose tolerance in population based study].
    Oizumi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():73-7. PubMed ID: 15779348
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.
    Garg AX; Prasad GV; Thiessen-Philbrook HR; Ping L; Melo M; Gibney EM; Knoll G; Karpinski M; Parikh CR; Gill J; Storsley L; Vlasschaert M; Mamdani M;
    Transplantation; 2008 Aug; 86(3):399-406. PubMed ID: 18698242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding criteria for living kidney donors: what are the limits?
    Textor S; Taler S
    Transplant Rev (Orlando); 2008 Jul; 22(3):187-91. PubMed ID: 18631876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients.
    Shishido S; Sato H; Asanuma H; Shindo M; Hataya H; Ishikura K; Hamasaki Y; Goto M; Ikeda M; Honda M
    Pediatr Transplant; 2006 Feb; 10(1):67-73. PubMed ID: 16499590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset diabetes mellitus after renal transplantation.
    Eckhard M; Schindler RA; Renner FC; Schief W; Padberg W; Weimer R; Bretzel RG; Brendel MD
    Transplant Proc; 2009; 41(6):2544-5. PubMed ID: 19715971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to assess for impaired glucose tolerance before transplantation and should these results influence the choice of calcineurin inhibitors?
    Filler G; Hadjiyannakis S
    Pediatr Transplant; 2006 Feb; 10(1):1-4. PubMed ID: 16499579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment for patients with impaired glucose tolerance].
    Tawaramoto K; Kaku K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Funagata study--impaired glucose tolerance is a risk factor for stroke in a Japanese sample].
    Daimon M; Oizumi T; Kato T
    Nihon Rinsho; 2010 May; 68(5):843-6. PubMed ID: 20446580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland.
    Wittek A; Sokalski B; Grzeszczak W; Strojek K
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):350-3. PubMed ID: 19536734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IFG and IGT in Europe and America: the present and prospective].
    Tsujii S; Kuzuya H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.